Home » Europe Moves to Suspend Merck Cholesterol Drug
Europe Moves to Suspend Merck Cholesterol Drug
The European Medicines Agency announced Friday that it had confirmed a recommendation to suspend a cholesterol drug treatment by Merck Sharp & Dohme Ltd. after concluding that the drug's benefits don't outweigh the risks.
Law360
Law360
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May